Download | < Back |
21 Oct 2022 | |
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform your good office regarding the inclusion of new names in the Category of Promoter/Promoter Group of the Company. | |
View all announcements for BLISS GVS PHARMA LTD. | Source: BSE India |